Isoforms of Neuropilin-2 Denote Unique Tumor-Associated Macrophages in Breast Cancer
Year: 2022
Type: article
Abstract: Tumor-associated macrophages (TAMs) exert profound influence over breast cancer progression, promoting immunosuppression, angiogenesis, and metastasis. Neuropilin-2 (NRP2), consisting of the NRP2a and NRP2b isoforms, is a co-receptor for heparin-binding growth factors including VEGF-C and Class 3 Semaphorins. Selective upregulation in response to environmental stimuli and independent signaling pathways endow the NRP2 isoforms with unique functionality, with NRP2b promoting increased Akt signaling via receptor tyrosine kinases including VEGFRs, MET, and PDGFR. Although NRP2 has been shown to regulate macrophage/TAM biology, the role of the individual NRP2a/NRP2b isoforms in TAMs has yet to be evaluated. Using transcriptional profiling and spectral flow cytometry, we show that NRP2 isoform expression was significantly higher in TAMs from murine mammary tumors. NRP2a/NRP2b levels in human breast cancer metastasis were dependent upon the anatomic location of the tumor and significantly correlated with TAM infiltration in both primary and metastatic breast cancers. We define distinct phenotypes of NRP2 isoform-expressing TAMs in mouse models of breast cancer and within malignant pleural effusions from breast cancer patients which were exclusive of neuropilin-1 expression. Genetic depletion of either NRP2 isoform in macrophages resulted in a dramatic reduction of LPS-induced IL-10 production, defects in phagosomal processing of apoptotic breast cancer cells, and increase in cancer cell migration following co-culture. By contrast, depletion of NRP2b, but not NRP2a, inhibited production of IL-6. These results suggest that NRP2 isoforms regulate both shared and unique functionality in macrophages and are associated with distinct TAM subsets in breast cancer.
Source: Frontiers in Immunology
Institutions: University of Pittsburgh, UPMC Hillman Cancer Center, VA Pittsburgh Healthcare System, University of Pittsburgh Medical Center, Magee-Womens Research Institute, Medical University of South Carolina, MUSC Hollings Cancer Center, Tsinghua University, Ralph H. Johnson VA Medical Center, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,950
Funders: U.S. Department of Defense, U.S. Department of Veterans Affairs, Susan G. Komen for the Cure, Pennsylvania Department of Health, Medical University of South Carolina, University of Pittsburgh, Susan G. Komen, Thoracic Surgery Foundation, National Institutes of Health, National Cancer Institute
OpenAlex ID: W4224928666
